TUG1 and androgen insensitivity syndrome: The current study aimed to estimate the levels of four ncRNAs: TUG1 and its target miR-21, NBAT1, and miR-335 to determine their potential use as diagnostic and prognostic biomarkers in AIS patients and their possible relation to stroke-related risk factors and the patient’s thyroid profile.